LFG
SRPT icon

Larson Financial Group’s Sarepta Therapeutics SRPT Stock Holding History

Larson Financial Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Sell
740
-15
-2% -$284 ﹤0.01% 2232
2026
Q1 		$16.4K Sell
755
-1,127
-60% -$21.8K ﹤0.01% 1958
2025
Q4 		$40.5K Buy
1,882
+851
+83% +$17.9K ﹤0.01% 1344
2025
Q3 		$19.9K Buy
1,031
+188
+22% +$3.35K ﹤0.01% 1650
2025
Q2 		$14.4K Buy
843
+8
+1% +$341 ﹤0.01% 1642
2025
Q1 		$53.3K Sell
835
-7,916
-90% -$833K ﹤0.01% 1004
2024
Q4 		$1.06M Buy
8,751
+2
+0% +$245 0.06% 232
2024
Q3 		$1.09M Buy
8,749
+8,249
+1,650% +$1.14M 0.06% 217
2024
Q2 		$79K Hold
500
– – 0.01% 705
2024
Q1 		$64.7K Hold
500
– – 0.01% 634
2023
Q4 		$48.2K Sell
500
-9
-2% -$863 ﹤0.01% 658
2023
Q3 		$61.7K Buy
509
+9
+2% +$1.02K 0.01% 556
2023
Q2 		$57.3K Hold
500
– – 0.01% 528
2023
Q1 		$68.9K Hold
500
– – 0.01% 486
2022
Q4 		$64.8K Hold
500
– – 0.01% 474
2022
Q3 		$55K Hold
500
– – 0.01% 455
2022
Q2 		$37K Hold
500
– – 0.01% 434
2022
Q1 		$39K Hold
500
– – 0.01% 417
2021
Q4 		$45K Hold
500
– – 0.01% 398
2021
Q3 		$46K Hold
500
– – 0.01% 314
2021
Q2 		$39K Hold
500
– – 0.01% 314
2021
Q1 		$37K Hold
500
– – 0.01% 302
2020
Q4 		$85K Hold
500
– – 0.03% 153
2020
Q3 		$70K Hold
500
– – 0.03% 159
2020
Q2 		$80K Hold
500
– – 0.04% 147
2020
Q1 		$49K Hold
500
– – 0.03% 159
2019
Q4 		$65K Hold
500
– – 0.04% 132
2019
Q3 		$38K Hold
500
– – 0.02% 171
2019
Q2 		$76K Hold
500
– – 0.06% 100
2019
Q1 		$60K Hold
500
– – 0.05% 101
2018
Q4 		$55K Buy
+500
New +$62.5K 0.05% 107

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Larson Financial Group's SRPT Position: Q2 2026 in Review

Larson Financial Group reduced its Sarepta Therapeutics (SRPT) stake by 2% in Q2 2026, selling an estimated $284 and leaving 740 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Larson Financial Group first reported a position in SRPT in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.09M in Q3 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Larson Financial Group held 740 shares of Sarepta Therapeutics worth $13.3K as of Q2 2026.
  • Larson Financial Group sold 15 Sarepta Therapeutics shares in Q2 2026, an estimated $284.
  • Sarepta Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2232 holding.
  • Larson Financial Group first reported a position in Sarepta Therapeutics in Q4 2018 and has held it in 31 quarters since.
  • Larson Financial Group's Sarepta Therapeutics position peaked at $1.09M in Q3 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.